Every material Form 8-K Avient filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Avient reported third quarter 2024 sales of $815.2 million, up from $753.7 million a year earlier, and GAAP diluted EPS from continuing operations of $0.41, up from $0.06. Adjusted EPS of $0.65 exceeded the company's $0.62 guidance and rose 14% from the prior year. The company narrowed its full-year 2024 adjusted EPS guidance to $2.63 to $2.67 from $2.55 to $2.70, and raised its dividend 5% to $1.08 annualized.
Third quarter sales rose 8% to $815.2 million from $753.7 million; GAAP diluted EPS was $0.41 versus $0.06
Adjusted EPS of $0.65 beat the $0.62 guidance and was up 14% from $0.57 in the prior year quarter
2024 adjusted EPS guidance narrowed to $2.63 to $2.67 from $2.55 to $2.70; adjusted EBITDA guidance is $525 million to $530 million from $515 million to $540 million
Quarterly dividend increased 5% to $1.08 annualized, the fourteenth consecutive annual increase; investor day set for December 4 in New York
Avient Corporation entered into an indenture on September 19, 2024 for $650 million of 6.250% senior unsecured notes due November 1, 2031, sold in a private transaction. The filing describes customary covenants, change-of-control repurchase at 101% of principal, and redemption terms, which add a new long-term debt obligation for the company.
Principal amount: $650 million of 6.250% Senior Notes due 2031
Interest paid semi-annually on May 1 and November 1, starting May 1, 2025; maturity November 1, 2031
Redemption permitted from September 15, 2027; change-of-control offer at 101% of principal
Indenture with U.S. Bank Trust Company, National Association, as trustee; filed as Exhibit 4.1
Avient reported second quarter 2024 sales of $849.7 million, up from $824.4 million a year earlier, and adjusted EPS of $0.76 versus $0.63, above its $0.71 guidance. The company raised its full-year 2024 adjusted EPS guidance to $2.55 to $2.70 from $2.50 to $2.65, and its adjusted EBITDA guidance to $515 million to $540 million from $510 million to $535 million.
Q2 sales were $849.7 million, up from $824.4 million, with organic sales up 5% excluding foreign exchange.
Q2 adjusted EPS was $0.76 versus $0.63 a year earlier and above the $0.71 guidance; GAAP EPS from continuing operations was $0.36 versus $0.24.
Full-year 2024 adjusted EPS guidance rose to $2.55 to $2.70 from $2.50 to $2.65.
Third quarter adjusted EPS is expected at $0.62, a 9% increase; Investor Day is set for December 4 in New York City.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Avient filing is on SEC EDGAR ↗. 8-K briefs of other companies →